ASLAN PHARMACEUTICALS LTD - ADS (ASLN) Institutional Ownership

13F Institutional Holders and Ownership History from Q2 2018 to Q4 2023

Type / Class
Equity / ADS
Symbol
ASLN on Nasdaq
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Institutional Holders of ASLAN PHARMACEUTICALS LTD - ADS (ASLN) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2023 Q4 0 $0 -$1,068,181 0
2023 Q3 568,182 $1,068,181 -$4,272,720 $1.88 1
2023 Q2 2,840,908 $10,369,314 -$4 $3.65 1
2023 Q1 2,840,909 $1,636,364 -$5,410,524 $0.58 1
2022 Q4 17,570,184 $6,433,524 -$2,136,383 $0.36 23
2022 Q3 21,211,445 $12,645,664 -$693,458 $0.60 26
2022 Q2 22,438,552 $11,123,647 -$590,249 $0.50 24
2022 Q1 23,977,302 $21,483,764 -$589,402 $0.90 28
2021 Q4 26,039,068 $29,160,000 +$2,339,195 $1.12 30
2021 Q3 23,774,879 $42,318,000 -$10,528,580 $1.78 36
2021 Q2 26,642,951 $87,921,000 +$674,544 $3.30 30
2021 Q1 26,398,583 $88,432,375 +$74,078,794 $3.35 40
2020 Q4 4,284,158 $7,841,000 +$1,595,437 $1.83 11
2020 Q3 3,408,553 $6,477,000 -$153,330 $1.90 7
2020 Q2 3,488,801 $6,974,000 +$161,027 $2.00 9
2020 Q1 3,364,694 $3,432,000 -$82,580 $1.02 10
2019 Q4 3,294,140 $6,686,000 +$2,187,000 $2.03 14
2019 Q3 2,279,773 $3,944,000 -$39,745 $1.73 5
2019 Q2 2,293,688 $7,041,000 -$920,855 $3.07 7
2019 Q1 2,509,668 $10,698,000 -$1,914,840 $4.22 8
2018 Q4 2,997,835 $10,965,000 -$1,773,957 $3.66 8
2018 Q3 3,479,535 $27,622,000 -$152,322 $7.98 7
2018 Q2 3,498,856 $31,034,000 +$31,034,000 $8.90 7